![A Novel Mechanism of Action for Anti-Thymocyte Globulin: Induction of CD4+CD25+Foxp3+ Regulatory T Cells | American Society of Nephrology A Novel Mechanism of Action for Anti-Thymocyte Globulin: Induction of CD4+CD25+Foxp3+ Regulatory T Cells | American Society of Nephrology](https://jasn.asnjournals.org/content/jnephrol/17/10/2844/F2.large.jpg)
A Novel Mechanism of Action for Anti-Thymocyte Globulin: Induction of CD4+CD25+Foxp3+ Regulatory T Cells | American Society of Nephrology
![26. Immunomodulation and immunotherapy: Drugs, cytokines, cytokine receptors, and antibodies - Journal of Allergy and Clinical Immunology 26. Immunomodulation and immunotherapy: Drugs, cytokines, cytokine receptors, and antibodies - Journal of Allergy and Clinical Immunology](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/8af802c0-404c-4eae-a723-0405cede0a14/gr1_lrg.jpg)
26. Immunomodulation and immunotherapy: Drugs, cytokines, cytokine receptors, and antibodies - Journal of Allergy and Clinical Immunology
![IJMS | Free Full-Text | Recent Topics on The Mechanisms of Immunosuppressive Therapy-Related Neurotoxicities | HTML IJMS | Free Full-Text | Recent Topics on The Mechanisms of Immunosuppressive Therapy-Related Neurotoxicities | HTML](https://www.mdpi.com/ijms/ijms-20-03210/article_deploy/html/images/ijms-20-03210-g001a.png)
IJMS | Free Full-Text | Recent Topics on The Mechanisms of Immunosuppressive Therapy-Related Neurotoxicities | HTML
![Avens Publishing Group - Inducing All Our 'Low-Risk' Transplant Candidates: Shall We Or Shall We Not? Avens Publishing Group - Inducing All Our 'Low-Risk' Transplant Candidates: Shall We Or Shall We Not?](https://www.avensonline.org/fulltextarticles/wp-content/uploads/2017/05/JUN-2380-0585-04-0018-Fig3.png)
Avens Publishing Group - Inducing All Our 'Low-Risk' Transplant Candidates: Shall We Or Shall We Not?
![Toxins | Free Full-Text | Monoclonal Antibody Therapy and Renal Transplantation: Focus on Adverse Effects | HTML Toxins | Free Full-Text | Monoclonal Antibody Therapy and Renal Transplantation: Focus on Adverse Effects | HTML](https://www.mdpi.com/toxins/toxins-06-00869/article_deploy/html/images/toxins-06-00869-g001.png)
Toxins | Free Full-Text | Monoclonal Antibody Therapy and Renal Transplantation: Focus on Adverse Effects | HTML
![Paras Dedhia on Twitter: "Mechanism of action of Anti-thymocyte globulin in antibody med rejection (AMR) http://t.co/C3uuQYYCNg #NephPearls http://t.co/qeDaQ4UZyp" / Twitter Paras Dedhia on Twitter: "Mechanism of action of Anti-thymocyte globulin in antibody med rejection (AMR) http://t.co/C3uuQYYCNg #NephPearls http://t.co/qeDaQ4UZyp" / Twitter](https://pbs.twimg.com/media/COyldLEUsAAhRTC.png)
Paras Dedhia on Twitter: "Mechanism of action of Anti-thymocyte globulin in antibody med rejection (AMR) http://t.co/C3uuQYYCNg #NephPearls http://t.co/qeDaQ4UZyp" / Twitter
![Antithymocyte globulins in renal transplantation—from lymphocyte depletion to lymphocyte activation: The doubled-edged sword - ScienceDirect Antithymocyte globulins in renal transplantation—from lymphocyte depletion to lymphocyte activation: The doubled-edged sword - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0955470X16300799-gr1.jpg)